Page 3 - Abbott India

Abbott India reports 1.96% decline in Q4 net profit to Rs 110.97 crore

Revenue from operations stood at Rs 961.20 crorefor the quarter under consideration as against Rs 906.31 crore for the same period year ago

Abbott India up 19% as parent firm gets US FDA nod for rapid COVID-19 test

Abbott Laboratories is unveiling a COVID-19 test that can tell if someone is infected in as little as five minutes

Abbott India Q2 net up 30% at Rs 178 crore, total income rises 8%

The company had posted a profit of Rs 137.68 crore for the year-ago period, Abbott India said in a filing to BSE

Abbott India hits all-time high, surges 35% in two months

Abbott India had reported a 42 per cent year-on-year (YoY) jump in net profit at Rs 117 crore for Q1FY20.

Healthy sales in branded portfolio lift Abbott India's margins in Q1

Incremental growth to be led by new launches, expansion into new therapies

Nestle, Abbott India, Asian Paints, Pidilite hit new highs on good earnings

Nestle India gained 4% to Rs 12,266 apiece, surging 7% during current week, after the company reported a 11% year-on-year (YoY) rise in net profit to Rs 438 crore for the quarter ended June 2019.

Abbott India Q3 net up marginally at Rs 117 cr, revenue rises to Rs 947 cr

Abbott India's revenue from operations of the company stood at Rs 947.65 crore for the third quarter

Abbott India ups vaccines play, to launch products in infant segment

According to analysts, AIL's presence in the high-margin vaccine segment is likely to drive its future growth

Abbott looks beyond product portfolio to generate trust and recall

The pharma major walks around the prescribed lines to build a corporate identity beyond the medicines in its Indian portfolio

Abbott excels on power of brands, outpaces MNC peers on sales growth

The growth has come at a time when GST implementation affected most Indian pharma companies including Abbott's MNC peers

Abbott India Q2 net surges 83% at Rs 138 cr on robust sales

The total income of the company also rose to Rs 946.04 crore for the July-September quarter of 2017-18

Abbott India soars 20% on strong Q2 results

The stock was locked in upper circuit of 20% at Rs 5,401, also its 52-week high on the BSE.

NPPA allows Abbott to discontinue bioresorbable stent over safety concerns

NPPA decided to allow withdrawal under exceptional circumstances and by relaxing mandatory six months prior intimation in public interest

Abbott to discontinue sales of fully biodegradable stent

Abbott has been trying to withdraw its stent from India since the NPPA capped coronary stent prices

Abbott India Q1 net profit down 35% at Rs 48 crore

The firm had posted the net profit of Rs 74.01 crore in the same quarter last financial year

Chemists lock horns with Abbott over expired drugs

Regular disposal of medicines is for preventing contamination, toxicity and drug resistance

Did Abbot use India's doctor-pharma nexus to push through an untested drug?

Health camps have become an industry-wide marketing gimmick in India

Abbott India names Ambati Venu as MD

In February this year, Abbott India announced resignation of its managing director Rehan A Khan